A mixed-compound listing containing one peptide, MOTS-c, alongside NAD+ and 5-Amino-1MQ.
Listing checked October 4, 2026 · Original AI-assisted notes · Not reviewed by a medical professional
DECLARED COMPOSITION
120 mg total
3 ingredients
NAD+100 mg
MOTS-c10 mg
5-Amino-1MQ10 mg
Seller-declared ingredient masses. Bar widths show mass proportions, not potency, molecular structure, or an administration schedule.
What the supplier lists
Format needs confirmation: listing title gives 120 mg; an ingredient table labels its amounts per capsule. The composition below is attributed to this listing; it is not an independent measurement.
Declared composition · BioLongevity Labs · October 4, 2026
Listed ingredient
Declared amount
Identity & research context
NAD+
100 mg
Non-peptide compound; no dedicated PepsRadar research profile yet.
Not every ingredient in a product sold under a peptide category is a peptide. The source's per-capsule wording also needs clarification before assigning a package format. Amounts below reproduce the declared composition without resolving that discrepancy.
These are selected studies of individual ingredients or related identities. They did not validate the seller's finished blend. Open the linked profile for the population, design, results, and limitations.
INGREDIENT / RELATED IDENTITY
A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. · 2019
Human metabolic pilot study · 2019
What did this publication test, and what did it find?
A product description or general purity claim does not verify every ingredient or ratio in a purchased lot. Match the lot identifier, analytes, methods, and quantitative results to the specific material; a certificate does not establish a clinical outcome.
Educational product reference. No dosing, mixing, or administration instructions are provided. Medical and full-formulation evidence review remain pending.